Morgan Stanley Elevation Oncology, Inc. Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Elevation Oncology, Inc. stock. As of the latest transaction made, Morgan Stanley holds 951,089 shares of ELEV stock, worth $542,120. This represents 0.0% of its overall portfolio holdings.

Number of Shares

951,089

Previous 1,273,563 25.32%

Holding current value

$542,120

Previous $3.44 Million 83.42%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.56 - $3.02 $180,585 - $973,871	-322,474 Reduced 25.32%	951,089 $570,000
Q2 2024 Oct 17, 2024	BUY	$2.35 - $5.17 $2.93 Million - $6.44 Million	1,245,491 Added 4436.77%	1,273,563 $3.44 Million
Q2 2024 Aug 14, 2024	BUY	$2.35 - $5.17 $2.93 Million - $6.44 Million	1,245,491 Added 4436.77%	1,273,563 $3.44 Million
Q1 2024 Oct 17, 2024	SELL	$0.59 - $5.13 $734,839 - $6.39 Million	-1,245,491 Reduced 97.8%	28,072 $144,000
Q1 2024 Aug 16, 2024	BUY	$0.59 - $5.13 $14,540 - $126,428	24,645 Added 719.14%	28,072 $144,000
Q1 2024 May 15, 2024	BUY	$0.59 - $5.13 $14,540 - $126,428	24,645 Added 719.14%	28,072 $144,000
Q4 2023 Aug 16, 2024	SELL	$0.38 - $0.69 $482,651 - $876,393	-1,270,136 Reduced 99.73%	3,427 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.4 - $5.06 $203,032 - $733,816	-145,023 Reduced 97.69%	3,427 $5,000
Q1 2023 May 15, 2023	BUY	$0.75 - $2.55 $111,251 - $378,254	148,335 Added 128986.96%	148,450 $282,000
Q2 2022 Oct 27, 2022	SELL	$1.26 - $3.94 $7,842 - $24,522	-6,224 Reduced 98.19%	115 $0
Q2 2022 Aug 15, 2022	SELL	$1.26 - $3.94 $7,842 - $24,522	-6,224 Reduced 98.19%	115 $0
Q1 2022 Oct 27, 2022	BUY	$2.34 - $6.41 $14,564 - $39,895	6,224 Added 5412.17%	6,339 $16,000
Q1 2022 May 13, 2022	SELL	$2.34 - $6.41 $3,664 - $10,038	-1,566 Reduced 19.81%	6,339 $16,000
Q4 2021 Feb 14, 2022	BUY	$4.15 - $8.86 $26,248 - $56,039	6,325 Added 400.32%	7,905 $48,000
Q3 2021 Nov 15, 2021	BUY	$7.66 - $16.11 $12,102 - $25,453	1,580 New	1,580 $12,000

Others Institutions Holding ELEV

# of Institutions

Shares Held

45.4M

Call Options Held

700

Put Options Held

27.6K

View Full List

About Elevation Oncology, Inc.

Ticker ELEV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 23,300,900
Market Cap $13.3M
Description
Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...

More about ELEV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account